Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drugUS Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Share XSanders calls on FDA to allow low-cost rivals to $375k Catalyst drughttps://pharmaphorum.com/news/sanders-calls-on-fda-to-allow-low-cost-rivals-to-375k-catalyst-drug/
Catalyst sparks price row in US with $300,000 rare disease drugThe controversy over rising drug prices in the US has been reignited after it emerged that the yearly Share XCatalyst sparks price row in US with $300,000 rare disease drughttps://pharmaphorum.com/news/catalyst-sparks-price-row-in-us-with-300000-rare-disease-drug/
